» Articles » PMID: 1506327

The Postantifungal Effect of 5-fluorocytosine on Candida Albicans

Overview
Date 1992 Feb 1
PMID 1506327
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The in-vitro postantifungal effect (PAFE) of 5-fluorocytosine for Candida albicans for short periods of time was investigated. Yeast cells were exposed for 0.5, 1 or 2 h to a range of concentrations (0.1-3.2 mg/L) of 5-fluorocytosine. The PAFE was quantitated by determinations of the number of colony forming units at hourly intervals (0-10 h) after removal of the drug by dilution. The length of the PAFE was dependent upon the concentration of 5-fluorocytosine and the duration of exposure. An exposure time of 0.5 h resulted in PAFE's ranging from 0 to 4.2 h. Exposure times of 1 and 2 h resulted in longer PAFEs and in many instances suppression of cell growth was seen for the entire evaluation period (up to ten hours).

Citing Articles

Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications.

Autmizguine J, Guptill J, Cohen-Wolkowiez M, Benjamin Jr D, Capparelli E Drugs. 2014; 74(8):891-909.

PMID: 24872147 PMC: 4073603. DOI: 10.1007/s40265-014-0227-3.


Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Groll A, Kolve H Eur J Clin Microbiol Infect Dis. 2004; 23(4):256-70.

PMID: 15015031 DOI: 10.1007/s10096-004-1108-6.


Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.

Zhanel G, Craig W Clin Pharmacokinet. 1994; 27(5):377-92.

PMID: 7851055 DOI: 10.2165/00003088-199427050-00005.


Comparative studies on the postantifungal effect produced by the synergistic interaction of flucytosine and amphotericin B on Candida albicans.

Scalarone G, Mikami Y, Kurita N, Yazawa K, Miyaji M Mycopathologia. 1992; 120(3):133-8.

PMID: 1494357 DOI: 10.1007/BF00436389.